From the Motly Fool article by Reza...
After approval of Qsymia in the US, some American doctors were appalled by what they viewed as an irresponsible decision by the FDA. One of the key risks of Qsymia is birth defects. Dr. Daniel P. Lopez, M.D., F.A.C.O.G., an obstetrician and gynecologic surgeon in Los Angeles, in a recent posting blasted the FDA for their approval of Qsymia. Dr. Lopez cited a survey reported on WebMD.
No matter how many analysts, journalists, hedge funds and politicians back Qsymia, doctors ultimately write the prescriptions and every doctor I’ve talked to prefers Arena’s Belviq over Qsymia because of Belviq’s excellent safety profile. Belviq does not pose cardiovascular risks by raising the heart rate, and it does not cause birth defects.
CEO and founder of Arena, Jack Lief, has not sold a single share since founding the company. Have a look at Vivus management's heavy insider sales!
Is anyone else having a hard time finding the amount of shares Jack Lief, the CEO, actually owns. It appears to be -0- or close to it since all insiders together only own 0.53% of the company according to the latest report. So when I hear that Jack Lief hasn't sold a single share since founding the company, I have to wonder why he hasn't bought a significant amount instead of owning so very little. Is this another one of those no cash/free stock options for executives type company?
A further inspection of Insider Ownership and Insider Transactions show a plethora of stockoption exercises by officers at well under $2.00 with immediate sales up to $11.00/share, the latest transaction occurring 9-30-12. A total of 166,665 shares have been unloaded by officers in the past 12 months. A total of -0- shares have been purchased by officers during this same time period. Why do insiders not have their own cash on the line @ ARNA?